Last update :
12/12/2025
References   References 5084  
Type : Journal
Web link : https://ijpc.com/Abstracts/Abstract.cfm?ABS=5473

Research teams : Houston - Professional Compounding Centers of America (PCCA)
Authors : Davis C, Ip K, Banov D, Zdoryk O.
Title : Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease.
Reference : Int J Pharm Compound ; 29, 4: 279-290. 2025

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
Oral solutionCaptopril Antihypertensive
Stability in solutions Not specified powder 100 mg
® = ?
Ascorbic acid 500 mg
Citric acid 900 mg
Suspendit® >> 100 ml
2-8°C Protect from light
180 Day
Stability in solutions Not specified powder 500 mg
® = ?
Ascorbic acid 500 mg
Citric acid 900 mg
Suspendit® >> 100 ml
2-8°C Protect from light
180 Day
Oral solutionMetoprolol tartrate Anti-arrhythmic
Stability in solutions Not specified powder 100 mg
® = ?
Citric acid 500 mg
Citric acid 1% >> pH 3.6-4.6
NaOH 1% >> pH 3.6-4.6
Suspendit® >> 100 ml
20-25°C Protect from light
180 Day
Stability in solutions Not specified powder 1000 mg
® = ?
Citric acid 500 mg
Citric acid 1% >> pH 3.6-4.6
NaOH 1% >> pH 3.6-4.6
Suspendit® >> 100 ml
20-25°C Protect from light
180 Day

  Mentions Légales